Koers Bonus BioGroup Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
BONS
IL0004850116
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 195 mln. 743 mln. 182 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -38 mln. -145 mln. -35,54 mln. | Nettowinst (verlies) 2023 | -28 mln. -107 mln. -26,19 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 41,67 mln. 159 mln. 38,97 mln. | Nettoliquiditeiten 2023 | 14,82 mln. 56,41 mln. 13,86 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-5,79
x | K/w-verhouding 2023 |
-6,84
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 54,94% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shai Meretzki
FOU | Founder | 55 | 29-04-12 |
Yoni Livne
DFI | Director of Finance/CFO | 49 | 01-06-14 |
Atara Novak
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shai Meretzki
FOU | Founder | 55 | 29-04-12 |
Benjamin Shafir
BRD | Director/Board Member | 73 | 29-09-20 |
Gil Shapira
BRD | Director/Board Member | 65 | 29-04-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,60% | 128 mln. | |
-7,82% | 67,46 mln. | |
+14,87% | 61,68 mln. | |
+6,64% | 60,58 mln. |